Artivion (AORT) Net Margin (2010 - 2026)
Artivion posted quarterly Net Margin of 1.22% for Q1 2026, up 173.0% year-on-year from 0.45% in Q1 2025, and down 41.76% on a QoQ basis from 2.09% in Q4 2025.
Artivion (AORT) has 17 years of Net Margin data on file, last reported at 1.22% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin rose 173.0% year-over-year to 1.22%; the trailing twelve-month figure through Mar 2026 stood at 2.55% (up 803.0% YoY), and the FY2025 full-year result was 2.21%, up 565.0% from the prior year.
- Net Margin for Q1 2026 stood at 1.22%, down from 2.09% in the prior quarter.
- Across five years, Net Margin topped out at 7.73% in Q1 2024 and bottomed at 17.85% in Q3 2022.
- The 5-year median for Net Margin is 2.39% (2024), against an average of 3.78%.
- Peak annual rise in Net Margin reached 2805 bps in 2022, while the deepest fall reached 3250 bps in 2022.
- A 5-year view of Net Margin shows it stood at 2.73% in 2022, then sank by 255 bps to 4.24% in 2023, then tumbled by 299 bps to 16.94% in 2024, then soared by 112 bps to 2.09% in 2025, then sank by 42 bps to 1.22% in 2026.
- The last three Net Margin figures came in at 1.22% (Q1 2026), 2.09% (Q4 2025), and 5.73% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn | 1.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.22% |
| Dec 31, 2025 | 2.09% |
| Sep 30, 2025 | 5.73% |
| Jun 30, 2025 | 1.19% |
| Mar 31, 2025 | -0.51% |
| Dec 31, 2024 | -16.94% |
| Sep 30, 2024 | -2.39% |
| Jun 30, 2024 | -2.16% |
| Mar 31, 2024 | 7.73% |
| Dec 31, 2023 | -4.24% |
| Sep 30, 2023 | -11.16% |
| Jun 30, 2023 | -3.79% |
| Mar 31, 2023 | -16.26% |
| Dec 31, 2022 | 2.73% |
| Sep 30, 2022 | -17.85% |
| Jun 30, 2022 | -5.30% |
| Mar 31, 2022 | -4.39% |
| Dec 31, 2021 | -25.32% |
| Sep 30, 2021 | 14.66% |
| Jun 30, 2021 | -2.86% |
| Mar 31, 2021 | -4.41% |
| Dec 31, 2020 | -5.09% |
| Sep 30, 2020 | -4.41% |
| Jun 30, 2020 | -6.86% |
| Mar 31, 2020 | -10.03% |
| Dec 31, 2019 | -13.34% |
| Sep 30, 2019 | -0.20% |
| Jun 30, 2019 | 3.98% |
| Mar 31, 2019 | -0.44% |
| Dec 31, 2018 | -7.87% |
| Sep 30, 2018 | 2.42% |
| Jun 30, 2018 | 0.33% |
| Mar 31, 2018 | -6.22% |
| Dec 31, 2017 | -17.66% |
| Sep 30, 2017 | 3.01% |
| Jun 30, 2017 | 6.61% |
| Mar 31, 2017 | 4.93% |
| Dec 31, 2016 | 12.45% |
| Sep 30, 2016 | 6.61% |
| Jun 30, 2016 | 4.98% |
| Mar 31, 2016 | 5.91% |
| Dec 31, 2015 | -7.69% |
| Sep 30, 2015 | 5.84% |
| Jun 30, 2015 | -1.41% |
| Mar 31, 2015 | -0.81% |
| Dec 31, 2014 | 4.78% |
| Sep 30, 2014 | 6.27% |
| Jun 30, 2014 | 6.23% |
| Mar 31, 2014 | 2.96% |
| Dec 31, 2013 | 26.37% |
| Sep 30, 2013 | 8.74% |
| Jun 30, 2013 | 5.33% |
| Mar 31, 2013 | 6.17% |
| Dec 31, 2012 | -29.28% |
| Sep 30, 2012 | 4.60% |
| Jun 30, 2012 | 9.82% |
| Mar 31, 2012 | 3.07% |
| Dec 31, 2011 | 6.14% |
| Sep 30, 2011 | 6.81% |
| Jun 30, 2011 | 6.06% |
| Mar 31, 2011 | 5.52% |
| Dec 31, 2010 | 1.34% |
| Sep 30, 2010 | -10.66% |
| Jun 30, 2010 | 10.00% |